Griffith & Werner, Inc. Gilead Sciences, Inc. Transaction History
Griffith & Werner, Inc.
- $161 Billion
- Q1 2025
A detailed history of Griffith & Werner, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Griffith & Werner, Inc. holds 13,832 shares of GILD stock, worth $1.44 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
13,832
Previous 14,436
4.18%
Holding current value
$1.44 Million
Previous $1.33 Billion
16.23%
% of portfolio
0.96%
Previous 0.88%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,130Shares Held
988MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.1 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.48 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.3 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.05 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $131B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...